Krystal Biotech, Inc.
KRYS
$345.70
-$2.40-0.69%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 24.00% | 33.49% | 38.54% | 24.26% | 21.87% |
| Total Receivables | 24.43% | 23.01% | 21.65% | 33.23% | 7.95% |
| Inventory | 46.76% | 42.43% | 52.69% | 102.53% | 154.87% |
| Prepaid Expenses | 76.52% | 59.21% | 117.80% | 204.83% | 117.96% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 25.95% | 32.99% | 38.08% | 29.79% | 23.23% |
|
|
|||||
| Total Current Assets | 25.95% | 32.99% | 38.08% | 29.79% | 23.23% |
| Net Property, Plant & Equipment | 1.62% | 1.06% | -2.13% | -4.14% | -4.49% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 11,629.95% | 10,507.34% | 9,904.76% | 12,221.67% | 56.35% |
| Total Assets | 31.82% | 30.02% | 26.33% | 26.24% | 24.05% |
|
|
|||||
| Total Accounts Payable | -8.14% | 53.03% | -35.05% | -62.42% | 31.32% |
| Total Accrued Expenses | 51.04% | 43.09% | 53.95% | 70.87% | 110.19% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 11.81% | 32.16% | 45.52% | 31.42% | 18.81% |
| Total Finance Division Other Current Liabilities | 59.71% | 5.61% | -61.21% | -65.93% | -65.50% |
| Total Other Current Liabilities | 59.71% | 5.61% | -61.21% | -65.93% | -65.50% |
| Total Current Liabilities | 46.61% | 35.62% | 0.93% | 1.94% | 20.94% |
|
|
|||||
| Total Current Liabilities | 46.61% | 35.62% | 0.93% | 1.94% | 20.94% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -12.64% | -11.90% | 25.22% | 26.34% | 27.47% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 154.04% | 162.37% | 162.44% | 312.22% | 373.98% |
| Total Liabilities | 44.78% | 33.98% | 4.36% | 5.96% | 24.10% |
|
|
|||||
| Common Stock & APIC | 7.20% | 6.11% | 5.95% | 4.82% | 4.87% |
| Retained Earnings | 226.51% | 155.26% | 113.37% | 87.96% | 57.92% |
| Treasury Stock & Other | -474.68% | -516.15% | 697.89% | -27.25% | 282.49% |
| Total Common Equity | 30.60% | 29.66% | 28.87% | 28.45% | 24.05% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 30.60% | 29.66% | 28.87% | 28.45% | 24.05% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 30.60% | 29.66% | 28.87% | 28.45% | 24.05% |
|
|
|||||